KBC Group NV Cuts Stake in Healthpeak Properties, Inc. $DOC

Key Points

• KBC Group NV cut its Healthpeak Properties stake by 56.5% in the second quarter, selling 72,605 shares and retaining 55,798 shares valued at approximately $1.19 million. Institutional investors collectively own 93.57% of DOC.
• Analyst sentiment remains mostly neutral: Healthpeak has four Buy ratings and 15 Hold ratings, with a consensus price target of $21.44. Recent target increases ranged from $21 to $24.
• Healthpeak exceeded quarterly expectations, reporting $0.08 EPS versus $0.03 expected and revenue of $771.58 million, up 11.1% year over year. The company also declared a monthly dividend of $0.1017 per share, implying a 5.9% annualized yield.

KBC Group NV reduced its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 56.5% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 55,798 shares of the real estate investment trust's stock after selling 72,605 shares during the quarter. KBC Group NV's holdings in Healthpeak Properties were worth $1,194,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. CX Institutional increased its position in shares of Healthpeak Properties by 6.1% during the second quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock valued at $235,000 after acquiring an additional 633 shares in the last quarter. Fiduciary Trust Co increased its holdings in shares of Healthpeak Properties by 4.9% in the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock worth $264,000 after purchasing an additional 644 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock worth $721,000 after purchasing an additional 718 shares during the last quarter. Quantum Portfolio Management LLC lifted its holdings in shares of Healthpeak Properties by 2.5% during the first quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust's stock valued at $483,000 after purchasing an additional 728 shares in the last quarter. Finally, Intrua Financial LLC lifted its holdings in shares of Healthpeak Properties by 1.1% during the first quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust's stock valued at $1,096,000 after purchasing an additional 744 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on DOC. Scotiabank boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a "sector perform" rating in a report on Wednesday, May 27th. Wall Street Zen upgraded shares of Healthpeak Properties from a "sell" rating to a "hold" rating in a report on Sunday, May 10th. JPMorgan Chase & Co. lifted their target price on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 24th. Evercore lowered shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 target price for the company. in a research note on Monday, May 11th. Finally, BMO Capital Markets increased their price target on Healthpeak Properties from $20.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, June 15th. Four research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. According to MarketBeat, Healthpeak Properties presently has an average rating of "Hold" and a consensus target price of $21.44.

Healthpeak Properties Stock Performance

DOC opened at $20.78 on Friday. The firm has a market cap of $14.33 billion, a P/E ratio of 59.38, a PEG ratio of 3.20 and a beta of 1.01. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.95. The company has a 50 day simple moving average of $21.33 and a two-hundred day simple moving average of $18.90. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. The company had revenue of $771.58 million for the quarter, compared to analysts' expectations of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. Healthpeak Properties's revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties's payout ratio is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source